Inflammatory Arthritis in Patients with COVID-19

Overview

Journal Transl Res

Publisher Elsevier

Specialty Pathology

Date 2021 Feb 24

PMID 33626415

Citations 10

Authors

Richard Conway

Maximilian F Konig

Elizabeth R Graef

Kate Webb

Jinoos Yazdany

Alfred H J Kim

Affiliations

Soon will be listed here.

Abstract

Patients with inflammatory arthritis represent a possible high-risk group to COVID-19 due to their immunosuppressive regimen designed to maintain low disease activity. Thus, substantial effort has been put forth to understand the impact of COVID-19 on these patients. Patients with rheumatic diseases as a whole do not appear to be more susceptible to acquiring COVID-19. Furthermore, immunosuppression generally did not increase the likelihood of developing severe COVID-19, with the important exception of medium and high-dose glucocorticoid use. In addition, a small number of COVID-19 patients have developed new inflammatory arthritis; whether this represents an unmasking of previous subclinical disease or a bone fide virus-induced arthritis is unclear. Nevertheless, it appears that inflammatory arthritis patients currently on immunosuppression should continue their medication to prevent future flares and limit glucocorticoid usage. While this continues to be a rapidly evolving field, these data are reassuring to both patients with and providers treating inflammatory arthritides.

Citing Articles

Ismael A, Yves-Zakari K, Tchenadoyo B, Mamadou B, Nadege Y, Aziz A Clin Case Rep. 2024; 12(1):e8462.

PMID: 38268619 PMC: 10805996. DOI: 10.1002/ccr3.8462.

A case of de novo seronegative inflammatory oligoarthritis associated with COVID-19 infection.

Sung L, Surmachevska N, Rubio J Clin Immunol Commun. 2023; 2:159-161.

PMID: 38013974 PMC: 9580240. DOI: 10.1016/j.clicom.2022.10.001.

Kalavrytinos D, Kosmidis I J Orthop Case Rep. 2023; 13(6):40-43.

PMID: 37398528 PMC: 10308990. DOI: 10.13107/jocr.2023.v13.i06.3688.

Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis.

Swarnakar R, Roy S, Yadav S World J Exp Med. 2022; 12(6):108-110.

PMID: 36560976 PMC: 9764691. DOI: 10.5493/wjem.v12.i6.108.

Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin-Drug Interactions Exist?.

Mekky R, Elemam N, Eltahtawy O, Zeinelabdeen Y, Youness R Life (Basel). 2022; 12(10).

PMID: 36295089 PMC: 9604733. DOI: 10.3390/life12101654.

References

Mokuda S, Tokunaga T, Masumoto J, Sugiyama E . Angiotensin-converting Enzyme 2, a SARS-CoV-2 Receptor, Is Upregulated by Interleukin 6 through STAT3 Signaling in Synovial Tissues. J Rheumatol. 2020; 47(10):1593-1595. DOI: 10.3899/jrheum.200547. View

Haberman R, Castillo R, Chen A, Yan D, Ramirez D, Sekar V . COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes. Arthritis Rheumatol. 2020; 72(12):1981-1989. PMC: 7722024. DOI: 10.1002/art.41456. View

Mikuls T, Johnson S, Fraenkel L, Arasaratnam R, Baden L, Bermas B . American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2. Arthritis Rheumatol. 2020; 72(9):e1-e12. DOI: 10.1002/art.41437. View

Joo Y, Lim Y, Kim K, Park K, Park Y . Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019; 21(1):199. PMC: 6716891. DOI: 10.1186/s13075-019-1977-9. View

Soden M, Vasudevan H, Roberts B, Coelen R, Hamlin G, Vasudevan S . Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 2000; 43(2):365-9. DOI: 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E. View

Withrington R, Cornes P, Harris J, Seifert M, Berrie E, Taylor-Robinson D . Isolation of human immunodeficiency virus from synovial fluid of a patient with reactive arthritis. Br Med J (Clin Res Ed). 1987; 294(6570):484. PMC: 1245528. DOI: 10.1136/bmj.294.6570.484. View

Liew I, Mak T, Cui L, Vasoo S, Lim X . A Case of Reactive Arthritis Secondary to Coronavirus Disease 2019 Infection. J Clin Rheumatol. 2020; 26(6):233. PMC: 7437408. DOI: 10.1097/RHU.0000000000001560. View

Mendel A, Bernatsky S, Askanase A, Bae S, Clarke A, Costedoat-Chalumeau N . Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics. Ann Rheum Dis. 2020; 80(2):1-2. DOI: 10.1136/annrheumdis-2020-218164. View

Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban M . SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun Rev. 2020; 19(7):102575. PMC: 7200134. DOI: 10.1016/j.autrev.2020.102575. View

10.

Sharfstein J, Becker S, Mello M . Diagnostic Testing for the Novel Coronavirus. JAMA. 2020; 323(15):1437-1438. DOI: 10.1001/jama.2020.3864. View

11.

Zuo Y, Kanthi Y, Knight J, Kim A . The interplay between neutrophils, complement, and microthrombi in COVID-19. Best Pract Res Clin Rheumatol. 2021; 35(1):101661. PMC: 7831864. DOI: 10.1016/j.berh.2021.101661. View

12.

Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F . Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020; 19(7):102568. PMC: 7252115. DOI: 10.1016/j.autrev.2020.102568. View

13.

Talarico R, Stagnaro C, Ferro F, Carli L, Mosca M . Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. Lancet Rheumatol. 2020; 2(9):e518-e519. PMC: 7357970. DOI: 10.1016/S2665-9913(20)30216-2. View

14.

Lopez-Gonzalez M, Peral-Garrido M, Calabuig I, Tovar-Sugranes E, Jovani V, Bernabeu P . Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. 2020; 80(4):e58. DOI: 10.1136/annrheumdis-2020-217914. View

15.

Lennerz C, Madry H, Ehlhardt S, Venzke T, Zang K, Mehraein Y . Parvovirus B19-related chronic monoarthritis: immunohistochemical detection of virus-positive lymphocytes within the synovial tissue compartment: two reported cases. Clin Rheumatol. 2004; 23(1):59-62. DOI: 10.1007/s10067-003-0800-8. View

16.

Java A, Apicelli A, Liszewski M, Coler-Reilly A, Atkinson J, Kim A . The complement system in COVID-19: friend and foe?. JCI Insight. 2020; 5(15). PMC: 7455060. DOI: 10.1172/jci.insight.140711. View

17.

Pluss M, Chehab G, Korsten P . Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey. Ann Rheum Dis. 2020; 80(4):e52. DOI: 10.1136/annrheumdis-2020-217967. View

18.

Walker-Bone K, Doherty E, Sanyal K, Churchill D . Assessment and management of musculoskeletal disorders among patients living with HIV. Rheumatology (Oxford). 2016; 56(10):1648-1661. PMC: 5483171. DOI: 10.1093/rheumatology/kew418. View

19.

Cowling B, Ali S, Ng T, Tsang T, Li J, Fong M . Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020; 5(5):e279-e288. PMC: 7164922. DOI: 10.1016/S2468-2667(20)30090-6. View

20.

Danssaert Z, Raum G, Hemtasilpa S . Reactive Arthritis in a 37-Year-Old Female With SARS-CoV2 Infection. Cureus. 2020; 12(8):e9698. PMC: 7486113. DOI: 10.7759/cureus.9698. View